Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.

Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.

Item
http://www.wikidata.org/entity/Q39170559
Surgery in the era of the 'omics revolutionReactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.The mutational profile and infiltration pattern of murine MLH1-/- tumors: concurrences, disparities and cell line establishment for functional analysis.Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens.Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics.Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer.Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir.Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.Cellular vaccination of MLH1-/- mice - an immunotherapeutic proof of concept study.T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours.
P2860

Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.

Item
http://www.wikidata.org/entity/Q39170559
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Frameshift-derived neoantigens ...... r treating MSI+ blood cancers.
@en
Frameshift-derived neoantigens ...... r treating MSI+ blood cancers.
@nl
type
label
Frameshift-derived neoantigens ...... r treating MSI+ blood cancers.
@en
Frameshift-derived neoantigens ...... r treating MSI+ blood cancers.
@nl
prefLabel
Frameshift-derived neoantigens ...... r treating MSI+ blood cancers.
@en
Frameshift-derived neoantigens ...... r treating MSI+ blood cancers.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Frameshift-derived neoantigens ...... or treating MSI+ blood cancers
@en
P2093
P304
P31
P356
10.1016/J.EJCA.2013.02.035
P433
P478
P50
P577
P698
P921